These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36362676)

  • 21. The use of anterior segment optical coherence tomography (ASOCT) in demonstrating recurrence of vitreoretinal lymphoma (VRL) in the anterior vitreous.
    Diaconita V; Rihani H; Mares V; Nehemy MB; Bakri SJ; Pulido JS
    Int J Retina Vitreous; 2019; 5():19. PubMed ID: 31452937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Logistic regression models of cytokines in differentiating vitreoretinal lymphoma from uveitis.
    Tian S; Chen K; Xiao J; Zhou X; Shi H; Li Y; Huang H; Ma Y; Chen B; Wang Q; Guan M
    J Clin Lab Anal; 2022 Oct; 36(10):e24689. PubMed ID: 36098043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitreoretinal lymphoma: a 20-year review of incidence, clinical and cytologic features, treatment, and outcomes.
    Levasseur SD; Wittenberg LA; White VA
    JAMA Ophthalmol; 2013 Jan; 131(1):50-5. PubMed ID: 23307208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor Control and Visual Acuity Outcomes in Vitreoretinal Lymphoma with and without Sub-Retinal Pigment Epithelium Infiltration: Analysis of 125 Eyes of 70 Patients at a Single Ocular Oncology Center.
    Dalvin LA; Lim LS; Ancona-Lezama D; Mazloumi M; Chang M; Mashayekhi A; Shields CL
    Ophthalmol Retina; 2019 Nov; 3(11):998-1005. PubMed ID: 31358444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deep sequencing as a diagnostic tool in patients with suspected primary vitreoretinal lymphoma.
    Choo C; Cote O; Bostwick K; Regueiro M; Wells J; Grossniklaus HE; Gonzales J; Yeh S; Hinterwirth A; Doan T; Shantha JG
    Br J Ophthalmol; 2024 Aug; ():. PubMed ID: 39122354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
    Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
    Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential Diagnosis of Vitreoretinal Lymphoma by Detection of MYD88 Mutation in Aqueous Humor With Ultrasensitive Droplet Digital Polymerase Chain Reaction.
    Hiemcke-Jiwa LS; Ten Dam-van Loon NH; Leguit RJ; Nierkens S; Ossewaarde-van Norel J; de Boer JH; Roholl FF; de Weger RA; Huibers MMH; de Groot-Mijnes JDF; Kuiper JJW
    JAMA Ophthalmol; 2018 Oct; 136(10):1098-1104. PubMed ID: 30027272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-Throughput MicroRNA Profiling of Vitreoretinal Lymphoma: Vitreous and Serum MicroRNA Profiles Distinct from Uveitis.
    Minezaki T; Usui Y; Asakage M; Takanashi M; Shimizu H; Nezu N; Narimatsu A; Tsubota K; Umazume K; Yamakawa N; Kuroda M; Goto H
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32545709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Challenges in the diagnosis and management of vitreoretinal lymphoma - Clinical and basic approaches.
    Takase H; Arai A; Iwasaki Y; Imai A; Nagao T; Kawagishi M; Ishida T; Mochizuki M
    Prog Retin Eye Res; 2022 Sep; 90():101053. PubMed ID: 35210172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitreous Humor Proteomic Profile in Patients With Vitreoretinal Lymphoma.
    Komatsu H; Usui Y; Tsubota K; Fujii R; Yamaguchi T; Maruyama K; Wakita R; Asakage M; Hamada K; Yamakawa N; Nezu N; Ueda K; Goto H
    Invest Ophthalmol Vis Sci; 2023 Dec; 64(15):2. PubMed ID: 38038618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multimodal imaging characteristics in eyes with vitreoretinal lymphoma treated with intravitreal rituximab.
    Rishi P; Maitra P; Das K; Rishi E; Manchegowda PT
    Int Ophthalmol; 2021 Aug; 41(8):2711-2722. PubMed ID: 33834345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytologic and Molecular Diagnostics for Vitreoretinal Lymphoma: Current Approaches and Emerging Single-Cell Analyses.
    Tan WJ; Wang MM; Ricciardi-Castagnoli P; Chan ASY; Lim TS
    Front Mol Biosci; 2020; 7():611017. PubMed ID: 33505989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitreous proteomics, a gateway to improved understanding and stratification of diverse uveitis aetiologies.
    Schrijver B; Kolijn PM; Ten Berge JCEM; Nagtzaam NMA; van Rijswijk ALCT; Swagemakers SMA; van der Spek PJ; Missotten TOAR; van Velthoven MEJ; de Hoog J; van Hagen PM; Langerak AW; Dik WA
    Acta Ophthalmol; 2022 Jun; 100(4):403-413. PubMed ID: 34318583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PreservCyt Is an Optimal Fixative that Permits Cytologic and Molecular Analyses of Vitreoretinal Lymphoma Biopsies.
    Wang MM; Tan WJ; Lim TS; Chan ASY
    Ocul Immunol Inflamm; 2021 Apr; 29(3):430-439. PubMed ID: 31418635
    [No Abstract]   [Full Text] [Related]  

  • 35. Electroretinographic and Optical Coherence Tomographic Evaluations of Eyes with Vitreoretinal Lymphoma.
    Makita J; Yoshikawa Y; Kanno J; Igawa Y; Kumagai T; Takano S; Katsumoto T; Shoji T; Shibuya M; Shinoda K
    J Clin Med; 2023 Jun; 12(12):. PubMed ID: 37373651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitreoretinal lymphoma: changing trends in diagnosis and local treatment modalities at a single institution.
    Turaka K; Bryan JS; De Souza S; Gordon AJ; Kwong HM; Ziemianski MC; Reddy R; Sell CH
    Clin Lymphoma Myeloma Leuk; 2012 Dec; 12(6):412-7. PubMed ID: 22995952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical utility of cytokine analysis in the diagnosis and efficacy monitoring of vitreoretinal lymphoma.
    Kang H; Tao Y
    Int J Ophthalmol; 2022; 15(12):1893-1902. PubMed ID: 36536977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitreous levels of interleukin-35 as a prognostic factor in B-cell vitreoretinal lymphoma.
    Takeda A; Hasegawa E; Nakao S; Ishikawa K; Murakami Y; Hisatomi T; Arima M; Yawata N; Oda Y; Kimura K; Yoshikawa H; Sonoda KH
    Sci Rep; 2020 Sep; 10(1):15715. PubMed ID: 32973297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Features and Treatment Outcomes of Vitreoretinal Lymphoma according to Its Association with CNS Lymphoma.
    Cho BJ; Kim DY; Park UC; Lee JY; Yoon YH; Yu HG
    Ocul Immunol Inflamm; 2018; 26(3):365-371. PubMed ID: 29394118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Consensus Recommendations for the Diagnosis of Vitreoretinal Lymphoma.
    Carbonell D; Mahajan S; Chee SP; Sobolewska B; Agrawal R; Bülow T; Gupta V; Jones NP; Accorinti M; Agarwal M; Batchelor T; Biswas J; Cimino L; tenDam-van Loon NH; de-la-Torre A; Frenkel S; Pe'er J; Kramer M; Miserocchi E; Mochizuki M; Ness T; Rosenbaum JT; Sen HN; Simion M; Sitter H; Vasconcelos-Santos DV; Habot-Wilner Z; Coupland SE; Pulido JS; Smith J; Thorne JE; Zierhut M;
    Ocul Immunol Inflamm; 2021 Apr; 29(3):507-520. PubMed ID: 34009095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.